Barclays lowered the firm’s price target on Edgewell Personal Care to $40 from $41 and keeps an Equal Weight rating on the shares. The firm says Edgewell’s fiscal Q3 earnings and outlook were consistent with what it expected, with the exception of performance in Feminine Care, which declined more than its already below-consensus estimates.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EPC:
- Edgewell Announces Leadership Shuffle and Strategic Appointments
- Edgewell Personal Care Announces Third Quarter Fiscal 2024 Results
- EPC Upcoming Earnings Report: What to Expect?
- Prices of pads, tampons have risen faster than the price of food, WSJ says
- Edgewell Personal Care price target raised to $41 from $40 at Barclays